Abstract
Interleukin (IL)-21 is a new member of the type I cytokine superfamily. Although it is most homologous to IL-15, it has a unique receptor chain, IL-21R, that pairs with the γ-common cytokine receptor chain. The first experiments examining the biology of the IL-21 pathway reveal that it is a cytokine with effects on natural killer (NK) cells, T cells, and B cells. Mice deficient in the IL-21 R have also been made, and are being examined for the effects of the IL-21/IL-21R pathway in vivo. Here we summarize our current knowledge of this new cytokine pathway, and its role in innate and adaptive immunity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bazan JF: Structural design and mole cular evolution of acytokine receptor superfamily. Proc Nat Acad Sci USA 1990;87:6934–6938.
Kasaian MT, Whitters MJ, Carter LL Lowe LD, Jussif JM, Deng B, et al.: IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 2002;16:559–569.
Parrish-Novak J, Dillon SR, Nelson A, Hammond A, Sprecher C, Gross JA, et al.: Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000;408:57–63.
Ozaki K, Kikly K, Michalovich D, Young PR, Leonard WJ: Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Nat Acad Sci USA 2000;97:11439–11444.
Leonard WJ, O'Shea JJ: Jaks and STATs: biological implications. Ann Rev Immunol 1998;16:293–322.
Parrish-Novak J, Foster DC, Holly RD, Clegg CH: Interleukin-21 and the IL-21 receptor novel effectors of NK and T cell responses. J Leukocyte Biol 2002;72: 856–863.
Anderson DM, Johnson L, Glaccum MB, Copeland NG, Gilbert DJ, Jenkins NA, et al.: Chromosomal assignment and genomic structure of IL15. Genomics 1995;25: 701–706.
Wurster AL, Rodgers VL, Satoskar AR, Whitters MJ, Young DA, Collins M, Grusby MJ: Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically, inhibits the differentiation of naive Th cells into interferon gamma-producing Thl cells. J Exp Med 2002;196: 969–977.
Tagaya Y, Bamford RN, DeFilippis AP, Waldmann TA: IL-15: a pleiotropic cytokine with diverse recptor/signaling pathways whose expression is controlled at multiple levels. Immunity 1996;4:329–336.
Asao H, Okuyama C, Kumaki S, Ishii N, Tsuchiya S, Foster D, Sugamura K: cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol 2001;167:1–5.
Habib T, Senadheera S, Weinberg K, Kaushansky K: The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK 3. Biochemistry 2002;41:8725–8731.
Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Silvennoinen O: Signaling through the hematopoietic cytokine receptors. Ann Rev Immunol 1995;13:369–398.
Strengell M, Sareneva T, Foster D, Julkunen I, Matikainen S: IL-21 Up-re gulates the expression of genesassociated with innate immunity and Th1 response. J Immunol 2002;169:3600–3605.
Brenne AT, Baade Ro T, Waage A, Sundan A, Borset M, Hjorth-Hansen H: Interfleukin-21 is a growth and survival factor for human myeloma cells. Blood 2002;99: 3756–3762.
Suto A, Nakajima H, Hirose K, Suzuki K, Kagami SI, Seto Y, et al: Interleukin-21 prevents antigen-induced IgE production by inhibiting germline C ε transcription of IL-4-stimulated B cells. Blood 2002;100:4565–4573.
Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, et al: Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficientmice. J Exp Med 2000;191:771–780.
Ozaki K, Spolski R, Feng CG, Qi CF, Cheng J, Sher A, et al.: Acritical role for IL-21 inregulating immuno globulin production. Science 2002;298:1630–1634.
Van Leeuwen EM, Gamadia LE, Baars PA, Remmerswaal EB, Ten Berge IJ, Van Lier RA: Proliferation requirements of cytomegalovirus- specific, effector-type human CD8(+) T cells. J Immunol 2002;169: 5838–5843.
Kuhn R, Rajewsky K, Muller W: Generation and analysis of interleukin-4 deficient mice. Science 1991;254: 707–710.
Ueda C, Akasaka T, Kurata M, Maesako Y, Nishikori M, Ichinohasama R, et al.: The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma. Oncogene 2002:21:368–376.
Bennett F, Luxenberg D, Ling V, Wang I-M, Marquette K, Lowe D, et al.: PD-1 engagement upon TCR activitation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4 and IL-21, but not CD28, IL-7 and IL-15 responses. J. Immunol 2003; 170:711–718.